How does PFE's 2024 earnings trend compare to peers?

Pfizer's (PFE) 2024 earnings trend is significantly more robust than that of its peers, with all other companies in the Pharmaceuticals industry reporting net losses for the year:

|code|Ticker|Name|Date|Net Income|market_code|
|---|---|---|---|---|---|
|SISI|SISI.O|Shineco|20240331|5342124|186|
|RGLS|RGLS.O|Regulus Therapeutics|20240331|-8469000|186|
|TTNP|TTNP.O|Titan Pharmaceuticals|20240331|-1060000|186|
|NCNA|NCNA.O|Nucana|20240331|-8641180.6|186|
|PFE|PFE.N|Pfizer|20240331|3.123E9|169|
|QLGN|QLGN.O|Qualigen|20240331|-2032751|186|
|MIST|MIST.O|Milestone|20240331|-1.0354E7|185|
|ABVC|ABVC.O|ABVC BioPharma|20240331|-3981019|186|
|QNTM|QNTM.O|Quantum BioPharma|20240331|-2091425|186|
|IBRX|IBRX.O|ImmunityBio|20240331|-1.3413E8|185|